Revision history of "Project NK-001-2" (Q3679046)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2024

12 January 2024

7 December 2023

19 June 2023

11 June 2023

8 June 2023

11 August 2022

  • curprev 15:4315:43, 11 August 2022DG Regio talk contribs 38,583 bytes +25,067 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

14 January 2022

13 January 2022

6 December 2021

1 December 2021

  • curprev 08:0508:05, 1 December 2021DG Regio talk contribs 9,664 bytes +1,211 Created claim: summary (P836): Ziel des Projekts ist die Entwicklung eines neuen Arzneimittels zur Krebsbehandlung, das auf der Wirksamkeit der natürlichen Anti-Leukämie-Mechanismen von NK-Zellen (Natural Killers) basiert. Die Verwendung von NK-Zellen ist heute eine wichtige Alternative zur Behandlung von Tumorerkrankungen. Das Projekt untersucht auch die Anwendungen von NK-Zellen mit Mab (monoklonale Antikörper)., translated_summary

27 November 2021

  • curprev 12:3112:31, 27 November 2021DG Regio talk contribs 8,453 bytes −1,241 Removed claim: summary (P836): Le projet a pour but de développer un nouveau médicament pour le traitement du cancer basé sur l’efficacité des mécanismes naturels anti-leucémiques des cellules NK (Natural Killers). L‚utilization des cellules NK constitue aujourd‘hui une alternative majeure pour le traitement de pathologies tumorales. Le projet erforschen également les applications des cellules NK avec les Mab (anticorps monoclonaux)., Removing translation

26 November 2021

  • curprev 23:1123:11, 26 November 2021DG Regio talk contribs 9,694 bytes +1,241 Created claim: summary (P836): Le projet a pour but de développer un nouveau médicament pour le traitement du cancer basé sur l’efficacité des mécanismes naturels anti-leucémiques des cellules NK (Natural Killers). L‚utilization des cellules NK constitue aujourd‘hui une alternative majeure pour le traitement de pathologies tumorales. Le projet erforschen également les applications des cellules NK avec les Mab (anticorps monoclonaux)., translated_summary
  • curprev 14:4514:45, 26 November 2021DG Regio talk contribs 8,453 bytes +75 Changed label, description and/or aliases in de: translated_label

24 November 2021

18 November 2021

  • curprev 16:3816:38, 18 November 2021DG Regio talk contribs 7,947 bytes +75 Changed label, description and/or aliases in en: translated_label
  • curprev 16:3816:38, 18 November 2021DG Regio talk contribs 7,872 bytes +1,151 Created claim: summary (P836): The project aims to develop a new drug for the treatment of cancer based on the effectiveness of natural anti-leukemic mechanisms of NK cells (Natural Killers). The use of NK cells is now a major alternative for the treatment of tumour pathologies. The project also explores NK cell applications with Mab (monoclonal antibodies)., translated_summary

17 November 2021